How can we regulate medicines better?

被引：37

作者：

Garattini, Silvio

Bertele', Vittorio

机构：

来源：

BMJ-BRITISH MEDICAL JOURNAL | 2007年 / 335卷 / 7624期

关键词：

D O I：

10.1136/bmj.39281.615706.94

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：803 / 805

页数：5

共 19 条

[1]

Angell M., 2004, TRUTH DRUG CO THEY D

[2] Ten years of marketing approvals of anticancer drugs in Europe: regulatory policy and guidance documents need to find a balance between different pressures [J].

Apolone, G ;

Joppi, R ;

Bertele, V ;

Garattini, S .

BRITISH JOURNAL OF CANCER, 2005, 93 (05) :504-509

[3]

Chalmers L, 2004, NEW SCI, V181, P19

[4] Postmarketing surveillance - Lack of vigilance, lack of trust [J].

Fontanarosa, PB ;

Rennie, D ;

DeAngelis, CD .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2004, 292 (21) :2647-2650

[5] How can research ethics committees protect patients better? [J].

Garattini, S ;

Bertele, V ;

Li Bassi, L .

BMJ-BRITISH MEDICAL JOURNAL, 2003, 326 (7400) :1199-1201

[6] Adjusting Europe's drug regulation to public health needs [J].

Garattini, S ;

Bertele, V .

LANCET, 2001, 358 (9275) :64-67

[7]

Godlee F, 2006, BMJ-BRIT MED J, V2006, P333

[8] COX-2 inhibitors, other NSAIDs, and cardiovascular risk - The seduction of common sense [J].

Graham, David J. .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2006, 296 (13) :1653-1656

[9] Open access to industry's clinically relevant data - Urgently needed, but when will we get it, and in what form? [J].

Herxheimer, A .

BRITISH MEDICAL JOURNAL, 2004, 329 (7457) :64-65

[10] Association between competing interests and authors' conclusions: epidemiological study of ramdomised clinical trials published in the BMJ [J].

Kjaergard, LL ;

Als-Nielsen, B .

BMJ-BRITISH MEDICAL JOURNAL, 2002, 325 (7358) :249-252

← 1 2 →